Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.4.0.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current assets    
Cash $ 2,767 $ 7,851
Total current assets $ 2,767 $ 7,851
Fixed assets - net
Total Assets $ 2,767 $ 7,851
Current liabilities    
Accounts payable 660,906 622,129
Accrued interest payable 219,110 182,678
Notes payable - current - related parties 519,372 489,095
Notes payable - current, net 163,574 157,324
Stock subscription payable 31,583 55,882
Related party payables 440,156 412,656
Other payables 243,128 242,612
Total current liabilities 2,277,829 2,162,376
Total Liabilities 2,277,829 2,162,376
Stockholders' Deficit    
Common stock, $.00001 par value; 100,000,000 shares authorized; 67,751,068 and 60,251,068 shares issued and outstanding as of March 31, 2016 and December 31, 2015, respectively 677 602
Additional paid in capital 14,399,239 14,353,628
Accumulated deficit (16,634,108) (16,468,956)
Total Transbiotec, Inc. stockholders' deficit (2,234,192) (2,114,726)
Noncontrolling interest (40,870) (39,799)
Total Stockholders' Deficit (2,275,062) (2,154,525)
Total Liabilities and Stockholders' Deficit $ 2,767 $ 7,851